Newron Pharmaceuticals S.p.A. (SWX:NWRN)
Switzerland
· Delayed Price · Currency is CHF 18.28
-0.24 (-1.30%)
Dec 5, 2025, 5:30 PM CET
Newron Pharmaceuticals Revenue
Newron Pharmaceuticals had revenue of 11.90M EUR in the half year ending June 30, 2025, with 116.56% growth. This brings the company's revenue in the last twelve months to 59.88M, up 759.12% year-over-year. In the year 2024, Newron Pharmaceuticals had annual revenue of 51.39M with 467.41% growth.
Revenue (ttm)
59.88M EUR
Revenue Growth
+759.12%
P/S Ratio
6.52
Revenue / Employee
2.72M EUR
Employees
22
Market Cap
364.89M CHF
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 51.39M | 42.33M | 467.41% |
| Dec 31, 2023 | 9.06M | 2.96M | 48.62% |
| Dec 31, 2022 | 6.09M | 332.00K | 5.76% |
| Dec 31, 2021 | 5.76M | 504.00K | 9.59% |
| Dec 31, 2020 | 5.26M | -1.78M | -25.29% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Roche Holding AG | 63.49B |
| Novartis AG | 44.95B |
| Lonza Group AG | 7.09B |
| Galderma Group AG | 3.73B |
| Alcon | 8.12B |
| Sandoz Group AG | 8.42B |
| Straumann Holding AG | 2.58B |
| Sonova Holding AG | 3.85B |
Newron Pharmaceuticals News
- 3 months ago - Newron Pharmaceuticals S.p.A. (NWPHF) Presents at 17th World Congress of Biological Psychiatry (WCBP) - Slideshow - Seeking Alpha
- 8 months ago - Newron Pharmaceuticals reports FY results - Seeking Alpha